-Down to Earth Nearly 83 per cent medicines out of the ambit of price control policy, thus making them out of reach for most patients, say two recent reports Indicating failure of the National Pharmaceutical Pricing Policy (NPPP), 2012 and the Drugs Price Control Order (DPCO), 2013, two recently-released reports have stated that medicines are still not accessible and affordable for the citizens of the country. The reports that were jointly released...

-Down to Earth Demand farm income commission; urge political parties to make it an election issue A number of farmers' organisations got together on Thursday to demand a minimum living income equivalent to that of agricultural scientists for all farm households in the country and asked political parties to make it a part of their poll manifesto. Citing NSSO findings, they said the average monthly income of farm households in the country...

-The Telegraph New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies "escape routes" and promise little relief to consumers, a report released today has warned. The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside...

-Live Mint Mint examines why millions of women are missing from farms, factories, colleges, and offices in India, which has one of the lowest ratios of working women in the world Mumbai: Every monsoon, minivans ferrying women labourers can be seen making their way from the small sleepy town of Wardha to Waifad village, 18 kilometres away. Urban workers from Wardha have come to occupy an integral part of Waifad's farm...

-The Indian Express India's role in pharmaceutical patent wars has broadened access to healthcare. Recently, there were rumours that the United States Trade Representative (USTR) was getting ready to announce "trade enforcement actions" or sanctions against India over its intellectual property rights regime. The Obama administration has been under pressure from the US Chamber of Commerce and lobby groups, like the Pharmaceutical Research and Manufacturers of America, to take a tough stance...